Free-Space Quantum Electrodynamics with a single Rydberg superatom

The interaction of a single photon with an individual two-level system is the textbook example of quantum electrodynamics. Achieving strong coupling in this system so far required confinement of the light field inside resonators or waveguides. Here, we demonstrate strong coherent coupling between a single Rydberg superatom, consisting of thousands of atoms behaving as a single two-level system due to the Rydberg blockade, and a propagating light pulse containing only a few photons. The strong light-matter coupling in combination with the direct access to the outgoing field allows us to observe for the first time the effect of the interactions on the driving field at the single photon level. We find that all our results are in quantitative agreement with the predictions of the theory of a single two-level system strongly coupled to a single quantized propagating light mode. The demonstrated coupling strength opens the way towards interfacing photonic and atomic qubits and preparation of propagating non-classical states of light, two crucial building blocks in future quantum networks

On-orbit Validation of the Geolocation Accuracy of the GOES-16 Geostationary Lightning Mapper (GLM) Flashes Using Ground-based Laser Beacons

As part of the geolocation accuracy assessment of lightning flashes detected by the Geostationary Lightning Mapper (GLM) on the GOES-16 and GOES-17 satellites (Geostationary Operational Environmental Satellite), two satellite laser ranging stations employed laser beacon systems to generate transient light pulses that simulate natural lightning around 777.4 nm to validate the pre-launch spec of 5 km. The pulse width, repetition rate, wavelength, and power of the laser-pulses were configured to produce sufficient instrument response to be detected as synthetic lightning events by the GLM instrument. During the testing period from April 2017 to January 2018, the laser systems illuminated the GOES-16 satellite to observe diurnal variation of the GLM system response, with particular emphasis on geolocation accuracy. The final GOES-16 laser beacon tests, which used the latest updates of the geolocation algorithms implemented by the GOES-R Ground Segment, showed the offsets between the GLM geolocated location and the known laser locations were within 5 km

Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21

Intrachromosomal amplification of chromosome 21 is a heterogeneous chromosomal rearrangement occurring in 2% of childhood precursor B-cell acute lymphoblastic leukemia. There are no cell lines with iAMP21 and these abnormalities are too complex to faithfully engineer in animal models. As a resource for future functional and pre-clinical studies, we have created xenografts from intrachromosomal amplification of chromosome 21 leukemia patient blasts and characterised them by in-vivo and ex-vivo luminescent imaging, FLOW immunophenotyping, and histological and ultrastructural analysis of bone marrow and the central nervous system. Investigation of up to three generations of xenografts revealed phenotypic evolution, branching genomic architecture and, compared with other B-cell acute lymphoblastic leukemia genetic subtypes, greater clonal diversity of leukemia initiating cells. In support of intrachromosomal amplification of chromosome 21 as a primary genetic abnormality, it was always retained through generations of xenografts, although we also observed the first example of structural evolution of this rearrangement. Clonal segregation in xenografts revealed convergent evolution of different secondary genomic abnormalities implicating several known tumour suppressor genes and a region, containing the B-cell adaptor, PIK3AP1, and nuclear receptor co-repressor, LCOR, in the progression of B-ALL. Tracking of mutations in patients and derived xenografts provided evidence for co-operation between abnormalities activating the RAS pathway in B-ALL and for their aggressive clonal expansion in the xeno-environment. Bi-allelic loss of the CDKN2A/B locus was recurrently maintained or emergent in xenografts and also strongly selected as RNA sequencing demonstrated a complete absence of reads for genes associated with the deletions

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Background: Pancreatic cancer is the fourth most common cause of cancer related death in Western countries. Advantages in surgical techniques, radiation and chemotherapy had almost no impact on the long term survival of affected patients. Therefore, the need for better treatment strategies is urgent. HER2, a receptor tyrosine kinase of the EGFR family, involved in signal transduction pathways leading to cell growth and differentiation is overexpressed in a number of cancers, including breast and pancreatic cancer. While in breast cancer HER2 has already been successfully used as a treatment target, there are only limited data evaluating the effects of inhibiting HER2 tyrosine kinases in patients with pancreatic cancer. Methods: Here we report the design of a prospective, non-randomized multi-centered Phase II clinical study evaluating the effects of the Fluoropyrimidine-carbamate Capecitabine (Xeloda (R)) and the monoclonal anti-HER2 antibody Trastuzumab (Herceptin (R)) in patients with non-resectable, HER2 overexpressing pancreatic cancer. Patients eligible for the study will receive Trastuzumab infusions on day 1, 8 and 15 concomitant to the oral intake of Capecitabine from day 1 to day 14 of each three week cylce. Cycles will be repeated until tumor progression. A total of 37 patients will be enrolled with an interim analysis after 23 patients. Discussion: Primary end point of the study is to determine the progression free survival after 12 weeks of bimodal treatment with the chemotherapeutic agent Capecitabine and the anti-HER2 antibody Trastuzumab. Secondary end points include patient's survival, toxicity analysis, quality of life, the correlation of HER2 overexpression and clinical response to Trastuzumab treatment and, finally, the correlation of CA19-9 plasma levels and progression free intervals

Combined Cisplatinum and Laser Thermal Therapy for Palliation of Recurrent Head and Neck Tumors

In recent years endoscopically controlled laser-induced thermal therapy (LITT) has been increasingly accepted as a minimally invasive method for palliation of advanced or recurrent head and neck or gastrointestinal cancer. Previous studies have shown that adjuvant chemotherapy can potentiate endoscopic laser thermal ablation of obstructing tumors leading to improved palliation in advanced cancer patients. Eight patients with recurrent head and neck tumors volunteered to enroll as part of an ongoing phase II LITT clinical trial, and also elected to be treated with systemic chemotherapy (cisplatin, 80 mg/m2) followed 24 h later by palliative laser thermal ablation. Laser treatments were repeated in patients with residual disease or recurrence for a total of 27 LITT sessions. Four of the 8 patients treated with laser thermal chemotherapy remained alive after a median follow-up of 12 months. Of the 12 tumor sites treated, complete responses were located in the oral cavity (3), oropharynx (1), hypopharynx (1), maxillary sinus (1), and median survival for these patients was 9.5 months. This initial experience with cisplatinum-based laser chemotherapy indicates both safety and therapeutic potential for palliation of advanced head and neck cancer but this must be confirmed by longer follow-up in a larger cohort of patients

Controlled periodic illumination in semiconductor photocatalysis

Controlled periodic illumination is a hypothesis postulated in the early 1990s for enhancing the efficiency of semiconductor photocatalytic reactions. This technique has been proposed to improve photocatalytic efficiency by the nature of photon introduction alone. Before its application in semiconductor photocatalysis, controlled periodic illumination had been investigated in other fields including photosynthesis. This paper presents a detailed review of the state of the art research undertaken on the application of controlled periodic illumination in semiconductor photocatalysis. The review briefly introduces semiconductor photocatalysis, and then presents a detailed explanation of this technique, its importance to photocatalytic efficiency, an overview of previous results of its application in significant studies and present knowledge. Results from previous as well as some of the most recent studies indicate potential applications of controlled periodic illumination in areas other than just the improvement of the efficiency of the photocatalytic process

An earth system governance research agenda for carbon removal

Carbon dioxide removal (CDR) – the creation, enhancement, and upscaling of carbon sinks – has become a pillar of national and corporate commitments towards Net Zero emissions, as well as pathways towards realizing the Paris Agreement's ambitious temperature targets. In this perspective, we explore CDR as an emerging issue of Earth System Governance (ESG). We draw on the results of a workshop at the 2022 Earth System Governance conference that mapped a range of actors, activities, and issues relevant to carbon removal, and refined them into research questions spanning four intersecting areas: modeling and systems assessment, societal appraisal, policy, and innovation and industry. We filter these questions through the five lenses of the ESG framework and highlight several key ‘cross-cutting’ issues that could form the basis of an integrated ESG research agenda on CDR.</p

An earth system governance research agenda for carbon removal

Carbon dioxide removal (CDR) – the creation, enhancement, and upscaling of carbon sinks – has become a pillar of national and corporate commitments towards Net Zero emissions, as well as pathways towards realizing the Paris Agreement’s ambitious temperature targets. In this perspective, we explore CDR as an emerging issue of Earth System Governance (ESG). We draw on the results of a workshop at the 2022 Earth System Governance conference that mapped a range of actors, activities, and issues relevant to carbon removal, and refined them into research questions spanning four intersecting areas: modeling and systems assessment, societal appraisal, policy, and innovation and industry. We filter these questions through the five lenses of the ESG framework and highlight several key ‘cross-cutting’ issues that could form the basis of an integrated ESG research agenda on CDR

An earth system governance research agenda for carbon removal

Carbon dioxide removal (CDR) – the creation, enhancement, and upscaling of carbon sinks – has become a pillar of national and corporate commitments towards Net Zero emissions, as well as pathways towards realizing the Paris Agreement's ambitious temperature targets. In this perspective, we explore CDR as an emerging issue of Earth System Governance (ESG). We draw on the results of a workshop at the 2022 Earth System Governance conference that mapped a range of actors, activities, and issues relevant to carbon removal, and refined them into research questions spanning four intersecting areas: modeling and systems assessment, societal appraisal, policy, and innovation and industry. We filter these questions through the five lenses of the ESG framework and highlight several key ‘cross-cutting’ issues that could form the basis of an integrated ESG research agenda on CDR